BILL ANALYSIS                                                                                                                                                                                                    Ó



                                                                  AB 2034
                                                                  Page  1

          CONCURRENCE IN SENATE AMENDMENTS
          AB 2034 (Fuentes)
          As Amended 21, 2012
          Majority vote
           
           ----------------------------------------------------------------- 
          |ASSEMBLY:  |76-0 |(May 30, 2012)  |SENATE: |38-0 |(August 23,    |
          |           |     |                |        |     |2012)          |
           ----------------------------------------------------------------- 
            
           Original Committee Reference:    HEALTH  

           SUMMARY  :  Requires the Department of Health Care Services (DHCS) 
          to prepare a report on the coverage needs of the population 
          served by the Genetically Handicapped Persons Program (GHPP) 
          after implementation of the federal Patient Protection and 
          Affordable Care Act (Public Law 111-148) (ACA).  Specifies 
          issues to be addressed in the report including the extent to 
          which persons with genetic Amyotrophic Lateral Sclerosis (ALS) 
          will continue to have unmet medical needs.  

           The Senate amendments  :

          1)Require the DHCS to prepare a "report" in place of the 
            requirement to develop a plan and delete the requirement that 
            it be in consultation with the California Health Benefits 
            Exchange (Exchange).

          2)Specify that the report is on the coverage needs of the 
            population served by the GHPP and shall be submitted to the 
            Legislature by January 1, 2015.

          3)Delete the requirement that adding genetic ALS as a 
            GHPP-eligible condition be addressed and instead requires the 
            report to address the extent to which a person with genetic 
            ALS will continue to have unmet needs.

          4)Add a January 1, 2019 sunset date.  

           AS PASSED BY THE ASSEMBLY  , this bill required DHCS, in 
          consultation with the Exchange, to develop a plan for the GHPP 
          after implementation of the ACA that addresses adding genetic 
          ALS to the list of GHPP -covered conditions.

          FISCAL EFFECT  :  According to the Senate Appropriations 








                                                                  AB 2034
                                                                  Page  2

          Committee, this bill would:

          1)Cost between $50,000 and $100,000 (General Fund (GF) to 
            develop the plan.

          2)Create cost pressure to continue operating GHPP, likely from 
            $70 million to $100 million per year (70% GF).  Under current 
            law, GHPP is the payer of last resort for participants that 
            have other health care coverage, such as private insurance, 
            Medi-Cal, or Medicare.  About 40% of current program 
            participants have no other coverage, in which case the program 
            provides general health care coverage (with cost sharing).  
            Under the ACA, an unknown portion of the program population 
            will likely gain other health care coverage, reducing the 
            program's need to pay for basic health care costs. 

          3)Likely annual costs to provide services to ALS patients of 
            about $5 million per year (70% GF).  Based on current program 
            expenditures and cost sharing with other health care programs, 
            the average annual cost to provide services to newly eligible 
            participants will be about $65,000 per year, with an estimated 
            annual population of 75 new program participants.

           COMMENTS  :  According to the author, the purpose of this bill is 
          to provide access to aggressive multidisciplinary care for ALS 
          patients through a multi-disciplinary medical facility such as 
          the ALS Centers of Excellence.  According to the Muscular 
          Dystrophy Association, without assistive technologies such as 
          mechanical ventilation and feeding tubes, the average life 
          expectancy is three to five years after an ALS diagnosis and 
          about 4-10% live more than 10 years.  According to the ALS 
          Association, a majority of patients with adult-onset ALS, (90%) 
          have no family history of ALS and present as an isolated case.  
          ALS is directly hereditary in only a small percentage of 
          families.  Objective identification by genetic mutation is not 
          well enough developed to be determinative of the distinction 
          between the two types of ALS and currently family history is the 
          best tool for diagnosis.  

          GHPP, established in 1975, provides comprehensive health care 
          coverage for persons with specified genetic diseases including 
          cystic fibrosis; hemophilia; sickle cell disease and 
          thelassemia; chronic degenerative neurologic diseases including 
          Huntington's Disease, Friedrieich's Ataxia, and Joseph's 
          Disease; and metabolic diseases including phenylketonuria.  GHPP 








                                                                  AB 2034
                                                                  Page  3

          also provides access to social support services that may help 
          ameliorate the physical and psychological problems attendant to 
          genetically handicapping conditions.  

          GHPP clients with other health coverage, such as private 
          insurance may apply for GHPP benefits; however GHPP will only 
          cover limited services.  These include an annual outpatient 
          Special Care Center assessment, evaluation and case conference 
          and services not covered by the health plan.  Clients with 
          Medicare may also apply, however the Medicare Part A (hospital 
          care) or Part B (medical services) must be billed first and 
          prior authorization must be obtained from the GHPP.  Clients 
          with Medi-Cal may apply for GHPP benefits.  Medi-Cal clients, 
          including those enrolled in a Medi-Cal Managed Care plan, will 
          receive the same services they are receiving from Medi-Cal in 
          addition to the services available through the GHPP.  An example 
          of an additional service is Special Care Center services.  Once 
          the Medi-Cal clients are enrolled into this program, GHPP will 
          case manage their case.  Clients who are eligible for Medi-Cal 
          and Medicare (dual eligibles) must enroll in Medicare Part D for 
          drug coverage.  For clients who are Medicare only, Part D 
          enrollment is optional, however once enrolled clients are only 
          eligible for medications specifically excluded from coverage by 
          Medicare Part D.  


           Analysis Prepared by  :    Marjorie Swartz / HEALTH / (916) 
          319-2097 

          FN: 0005375